Immunity 48, 107–119 (2018)
The presence of natural killer (NK) cells in tumors correlates with a better prognosis. In Immunity, Glasner et al. show that secretion of interferon-γ (IFN-γ) by intratumoral NK cells after signaling via the NK cell receptor NKp46 (in humans) or Ncr1 (in mice) alters tumor architecture through induction of the extracellular matrix protein fibronectin1. Ncr1-deficient mice have less production of IFN-γ from intratumoral NK cells and worse tumor architecture and develop more metastases. Fibronectin1 is strongly induced in tumor cells by IFN-γ signaling, and its knockdown results in more-aggressive tumors. Treatment with recombinant IFN-γ or overexpression of Ncr1 in NK cells results in fewer metastases. In humans, expression of NKp46, IFN-γ, the IFN-γ receptor and fibronectin1 correlates with improved survival.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Visan, I. Tumor architecture. Nat Immunol 19, 206 (2018). https://doi.org/10.1038/s41590-018-0061-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0061-y